Wealthspire Advisors, LLC Novartis Ag Transaction History

Wealthspire Advisors, LLC

$18.8 Billion
Q3 2025

A detailed history of Wealthspire Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 3,535 shares of NVS stock, worth $465,029. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,535

Previous 4,552 22.34%

Holding current value

$465,029

Previous $550,000 17.64%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$113.5 - $129.73 $115,429 - $131,935	-1,017 Reduced 22.34%	3,535 $453,000
Q2 2025 Aug 11, 2025	BUY	$101.96 - $121.01 $43,129 - $51,187	423 Added 10.24%	4,552 $550,000
Q1 2025 May 09, 2025	BUY	$97.14 - $115.57 $128,127 - $152,436	1,319 Added 46.94%	4,129 $460,000
Q4 2024 Feb 03, 2025	SELL	$96.78 - $117.18 $42,583 - $51,559	-440 Reduced 13.54%	2,810 $273,000
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $14,009 - $15,957	132 Added 4.23%	3,250 $373,000

Q2 2024 Aug 08, 2024	SELL	$92.57 - $107.37 $2,499 - $2,898	-27 Reduced 0.86%	3,118 $331,000
Q1 2024 May 06, 2024	SELL	$95.27 - $108.47 $8,288 - $9,436	-87 Reduced 2.69%	3,145 $304,000
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $2,768 - $3,046	30 Added 0.94%	3,232 $326,000
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $72,563 - $80,529	766 Added 31.44%	3,202 $326,000
Q2 2023 Jul 31, 2023	SELL	$92.52 - $104.91 $34,695 - $39,341	-375 Reduced 13.34%	2,436 $245,000
Q1 2023 May 09, 2023	SELL	$80.03 - $92.81 $190,631 - $221,073	-2,382 Reduced 45.87%	2,811 $258,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $107,205 - $131,285	1,419 Added 37.6%	5,193 $471,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $46,855 - $54,799	628 Added 19.96%	3,774 $287,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $47,989 - $55,875	596 Added 23.37%	3,146 $266,000
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $200,114 - $226,368	-2,498 Reduced 49.48%	2,550 $224,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $287,079 - $317,444	-3,602 Reduced 41.64%	5,048 $442,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $707,397 - $822,961	8,650 New	8,650 $707,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $424,665 - $469,055	-4,982 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $19,288 - $22,746	-231 Reduced 4.43%	4,982 $426,000
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $190,100 - $229,937	2,435 Added 87.65%	5,213 $492,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $4,107 - $4,550	-50 Reduced 1.77%	2,778 $242,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $1.07 Million - $1.2 Million	-13,192 Reduced 82.35%	2,828 $247,000
Q1 2020 May 12, 2020	BUY	$70.67 - $99.01 $943,515 - $1.32 Million	13,351 Added 500.22%	16,020 $1.32 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $225,130 - $254,542	2,669 New	2,669 $253,000
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $85,111 - $97,349	-1,130 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $83,235 - $92,682	1,130 New	1,130 $97,000

Others Institutions Holding NVS

# of Institutions

1,601

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Novartis Ag Transaction History